• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对加拿大安大略省2019冠状病毒病(SARS-CoV-2)感染表观流行病学中年龄和性别差异检测进行调整的影响

Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV- 2 infection in Ontario, Canada.

作者信息

Bosco Savana, Peng Amy, Tuite Ashleigh R, Simmons Alison, Fisman David N

机构信息

Dalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.

Centre for Immunization Programs, Public Health Agency of Canada, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.

出版信息

BMC Infect Dis. 2025 Apr 23;25(1):589. doi: 10.1186/s12879-025-10968-6.

DOI:10.1186/s12879-025-10968-6
PMID:40269768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12020243/
Abstract

Communicable disease surveillance typically relies on case counts for estimates of risk, and counts can be strongly influenced by testing rates. In the Canadian province of Ontario, testing rates varied markedly by age, sex, geography and time over the course of the SARS-CoV-2 pandemic. We applied a standardization-based approach to test-adjustment to better understand pandemic dynamics from 2020 to 2022, and to better understand when test-adjustment is necessary for accurate estimation of risk. Case counts were adjusted for under-testing using a previously published standardization-based approach that estimates case numbers that would have been expected if the entire population was tested at the same rate as most-tested age and sex groups. After adjustment for under-testing, estimated case counts increased threefold and test-adjusted cases correlated better with SARS-CoV-2-attributed death than crude reported cases. Test-adjusted epidemic curves suggested, in contrast to reported case counts, that the first two pandemic waves were equivalent in size, and identified three distinct pandemic waves in 2022, due to the emergence of Omicron variants. Under-reporting was greatest in younger individuals, with variation explained partly by testing rates and prevalence of multigenerational households; test-adjustment resulted in little change in the epidemic curve during time periods when per capita testing rates exceeded 5.5%. We conclude that standardization-based adjustment for differential testing by age and sex results in a different understanding of the epidemiology of SARS-CoV-2 in Ontario. This methodology may offer a means of deriving adjusted estimates of infection incidence from surveillance data, accounting for fluctuations due to changing test practices.

摘要

传染病监测通常依靠病例数来估计风险,而病例数会受到检测率的强烈影响。在加拿大安大略省,在新冠疫情期间,检测率因年龄、性别、地理位置和时间而有显著差异。我们应用了一种基于标准化的检测调整方法,以更好地了解2020年至2022年的疫情动态,并更好地理解何时需要进行检测调整以准确估计风险。使用先前发表的基于标准化的方法对检测不足进行病例数调整,该方法估计如果整个人口以检测率最高的年龄和性别组相同的速率进行检测时预期的病例数。在对检测不足进行调整后,估计病例数增加了两倍,并且经检测调整后的病例与新冠病毒归因死亡的相关性比原始报告病例更好。与报告的病例数相比,经检测调整后的疫情曲线表明,前两波疫情规模相当,并在2022年识别出三波不同的疫情,这是由于奥密克戎变种的出现。报告不足在年轻人中最为严重,部分差异可由检测率和多代同堂家庭的患病率来解释;在人均检测率超过5.5%的时间段内,检测调整导致疫情曲线变化不大。我们得出结论,基于年龄和性别的差异检测的标准化调整导致对安大略省新冠病毒流行病学有不同的理解。这种方法可能提供一种从监测数据中得出感染发病率调整估计值的手段,同时考虑到检测实践变化引起的波动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/64253bcd56c1/12879_2025_10968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/df5b25ee718c/12879_2025_10968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/1955804919e8/12879_2025_10968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/62b4d13b79a2/12879_2025_10968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/64253bcd56c1/12879_2025_10968_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/df5b25ee718c/12879_2025_10968_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/1955804919e8/12879_2025_10968_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/62b4d13b79a2/12879_2025_10968_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3edc/12020243/64253bcd56c1/12879_2025_10968_Fig4_HTML.jpg

相似文献

1
Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV- 2 infection in Ontario, Canada.针对加拿大安大略省2019冠状病毒病(SARS-CoV-2)感染表观流行病学中年龄和性别差异检测进行调整的影响
BMC Infect Dis. 2025 Apr 23;25(1):589. doi: 10.1186/s12879-025-10968-6.
2
COVID-19 Case Age Distribution: Correction for Differential Testing by Age.COVID-19 病例年龄分布:按年龄差异检测校正。
Ann Intern Med. 2021 Oct;174(10):1430-1438. doi: 10.7326/M20-7003. Epub 2021 Aug 17.
3
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.南非印度马杜赖市首次新冠疫情期间的 SARS-CoV-2 感染和死亡率:一项前瞻性、主动监测研究。
Lancet Infect Dis. 2021 Dec;21(12):1665-1676. doi: 10.1016/S1473-3099(21)00393-5. Epub 2021 Aug 13.
4
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
5
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
6
Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.2020 年 4 月至 7 月期间加拿大多伦多 20 家无家可归者收容所中与 SARS-CoV-2 阳性相关的因素:一项重复横断面研究。
CMAJ Open. 2021 Mar 30;9(1):E302-E308. doi: 10.9778/cmajo.20200253. Print 2021 Jan-Mar.
7
COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys.英格兰不同社会人口群组的 COVID-19 检测和报告行为:基于人群的检测数据和社区流行监测调查数据的研究。
Lancet Digit Health. 2024 Nov;6(11):e778-e790. doi: 10.1016/S2589-7500(24)00169-9.
8
Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People.社区人群中严重急性呼吸综合征冠状病毒 2 感染概率预测模型的推导和内部验证。
J Gen Intern Med. 2021 Jan;36(1):162-169. doi: 10.1007/s11606-020-06307-x. Epub 2020 Oct 26.
9
Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.印度对 SARS-CoV-2 的实验室监测:2020 年 1 月 22 日至 4 月 30 日检测的表现和新冠肺炎的描述性流行病学。
Indian J Med Res. 2020 May;151(5):424-437. doi: 10.4103/ijmr.IJMR_1896_20.
10
Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.加拿大安大略省 SARS-CoV-2 检测和阳性的个体和社会决定因素:一项全人群研究。
CMAJ. 2021 May 17;193(20):E723-E734. doi: 10.1503/cmaj.202608. Epub 2021 Apr 27.

本文引用的文献

1
Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic.2019冠状病毒病大流行期间加拿大及四个同类国家的相对大流行严重程度。
Can Commun Dis Rep. 2023 May 1;49(5):197-205. doi: 10.14745/ccdr.v49i05a05.
2
The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.SARS-CoV-2 血清流行率在加拿大的演变:2020-2023 年的时间序列研究。
CMAJ. 2023 Aug 14;195(31):E1030-E1037. doi: 10.1503/cmaj.230249.
3
The changing profile of SARS-CoV-2 serology in Irish blood donors.爱尔兰献血者中新冠病毒血清学特征的变化
Glob Epidemiol. 2023 Dec;5:100108. doi: 10.1016/j.gloepi.2023.100108. Epub 2023 Apr 21.
4
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022.2020 年 3 月至 2022 年 5 月加拿大医院感染监测计划中 COVID-19 成年和儿科住院患者严重结局趋势。
JAMA Netw Open. 2023 Apr 3;6(4):e239050. doi: 10.1001/jamanetworkopen.2023.9050.
5
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.2021 年 5 月至 2022 年 1 月期间,加拿大安大略省青少年和儿科 SARS-CoV-2 病例住院疫苗有效性:一项回顾性队列研究。
PLoS One. 2023 Mar 31;18(3):e0283715. doi: 10.1371/journal.pone.0283715. eCollection 2023.
6
Estimating the test-adjusted incidence of infections identified through Public Health Ontario Laboratories in Peel region, Ontario, 2010-2018: a population-based study.估计 2010-2018 年安大略省皮尔地区安大略省公共卫生局实验室发现的 感染的检测调整发病率:一项基于人群的研究。
CMAJ Open. 2023 Jan 24;11(1):E62-E69. doi: 10.9778/cmajo.20210236. Print 2023 Jan-Feb.
7
US Life Expectancy in 2021 Lowest Since 1996.2021年美国预期寿命为1996年以来最低。
JAMA. 2023 Jan 24;329(4):280. doi: 10.1001/jama.2022.23562.
8
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.新型冠状病毒肺炎与主要动静脉血栓性疾病的相关性:一项针对英格兰和威尔士 4800 万成年人的基于人群的队列研究。
Circulation. 2022 Sep 20;146(12):892-906. doi: 10.1161/CIRCULATIONAHA.122.060785. Epub 2022 Sep 19.
9
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.SARS-CoV-2 核衣壳抗体的纵向动力学、血清学转换及其对血清流行病学研究的意义。
Emerg Infect Dis. 2022 Sep;28(9):1859-1862. doi: 10.3201/eid2809.220729. Epub 2022 Jul 22.
10
Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2.接种疫苗和未接种疫苗的住院 SARS-CoV-2 患者中严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的相对毒力。
Clin Infect Dis. 2023 Feb 8;76(3):e409-e415. doi: 10.1093/cid/ciac412.